The P2Y1 receptor is necessary for adenosine 5'-diphosphate-induced platelet aggregation

Blood

Volumn 92, Issue 1, 1998, Pages 152-159

  Hechler, Béatrice ^b   Léon, Catherine ^b   Vial, Catherine ^b   Vigne, Paul ^b   Frelin, Christian ^b   Cazenave, Jean Pierre ^b   Gachet, Christian ^a  

^a INSERM   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ADENYLATE CYCLASE; CALCIUM; FURA 2; PHOSPHATE; PURINE P2 RECEPTOR; THROMBOCYTE RECEPTOR; PURINE P2Y1 RECEPTOR;

ANIMAL CELL; ARTICLE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RAT; THROMBOCYTE; THROMBOCYTE AGGREGATION; ANIMAL; DRUG EFFECT; DRUG POTENTIATION; LEUKEMIA CELL LINE; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ADENOSINE DIPHOSPHATE; ANIMALS; BLOOD PLATELETS; HUMANS; JURKAT CELLS; PLATELET AGGREGATION; RATS; RECEPTORS, PURINERGIC P2; SIGNAL TRANSDUCTION;

EID: 0032105512     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.1.152.413k27_152_159     Document Type: Article

References (47)

1. Boeynaems JM, Pearson JD: P2 purinoceptors on vascular endothelial cells: Physiological significance and transduction mechanisms. Trends Pharmacol Sci 11:34,1990
2. Hellem AJ: The adhesiveness of human blood platelets in vitro. Scand J Clin Lab Invest 12:1,1960
3. Gaardner A, Jonsen J, Laland S, Hellem A, Owen PA: Adenosine diphosphate in red cells as a factor in adhesiveness of human blood platelets. Nature 192:531,1961
4. Maffrand JP, Bernat A, Delebassée D, Defreyn G, Cazenave JP, Gordon JL: ADP plays a key role in thrombogenesis in rats. Thromb Haemost 59:225,1988
5. Cattaneo M, Lecchi A, Randi AM, McGregor JL, Mannuci PM: Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate. Blood 80:2787,1992
6. Nurden P, Savi P, Heimann E, Bihour C, Herbert JM, Maffrand JP, Nurden A: An inherited bleeding disorder linked to a defective interaction between ADP and its receptor on platelets. J Clin Invest 95:1612,1995
7. Cusack NJ, Hourani SMO: Adenosine, adenine nucleotides and platelet function, in Phillis JW (ed): Adenosine and Adenine Nucleotides as Regulators of Cellular Function. Boca Raton, FL, CRC, 1991, p 121
8. Mills DC: ADP receptors on platelets. Thromb Haemost 76:835,1996
9. Cachet C, Hechler B, Léon C, Vial C, Ohlmann P, Cazenave JP: Purinergic receptors on blood platelets. Platelets 7:261,1996
10. Burnstock G: A basis for distinguishing two types of purinergic receptors, in Straub RW, Bolis L (eds): Cell Membrane Receptors for Drugs and Hormones: A Multidisciplinary Approach. New York, NY, Raven, 1978, p 107
11. Burnstock G, King BF: The numbering of cloned P2 purinoceptors. Drug Dev Res 38:67,1996
12. Heemskerk JWM, Sage SO: Calcium signalling in platelets and other cells. Platelets 5:295,1994
13. Hourani SMO, Hall DA: P2T purinoceptors: ADP receptors on platelets, in Chadwick DJ, Goode JA (eds): P2 Purinoceptors: Localization, Function and Transduction Mechanisms. Ciba Foundation Symposium. Chichester, UK, Wiley, 1996, p 53
14. Schrör K: The basic pharmacology of ticlopidine and clopidogrel. Platelets 4:252,1993
15. 1 . Biochem Pharmacol 40:2683,1990
16. Gachet C, Savi P, Ohlmann P, Jakobs KH, Maffrand JP, Cazenave JP: ADP receptor induced activation of guanine nucleotide binding proteins in rat platelet membranes. An effect selectively blocked by the thienopyridine clopidogrel. Thromb Haemost 68:79,1992
17. Mills DCB, Puri RN, Hu CJ, Minniti C, Grana G, Freedman M, Colman RF, Colman RW: Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase. Atheroscler Thromb 12:430,1992
18. Savi P, Laplace MC, Maffrand JP, Herbert JM: Binding of [3H]-2-methylthio-ADP to rat platelets: Effects of clopidogrel and ticlopidine. J Phamacol Exp Ther 269:772,1994
19. Gachet C, Cattaneo M, Ohlmann P, Hechler B, Lecchi A, Chevalier J, Cassel D, Mannuci PM, Cazenave JP: Purinoceptors on blood platelets: Further pharmacological and clinical evidence to suggest the presence of two ADP receptors. Br J Haematol 91:434,1995
20. Sage SO, Rink TJ: The kinetics of changes in intracellular calcium concentrations in fura-2-loaded human platelets. J Biol Chem 262:16364,1987
21. 1 not P2T purinoceptors in human platelets. J Biol Chem 271:2879,1996
22. 1 purinoceptors in human platelets and megakaryoblastic cell lines. Thromb Haemost 78:1500,1997
23. Cachet C, Hechler B, Léon C, Vial C, Leray C, Ohlmann P, Cazenave JP: Activation of ADP receptors and platelet function. Thromb Haemost 78:271,1997
24. 1 purinoceptor. Gene 171:295,1996
25. 1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells. FEBS Lett 403:26,1997
26. Webb TE, Simon J, Krishek BJ, Bateson AN, Smart TG, King BF, Burnstock G, Barnard EA: Cloning and functional expression of a brain G-protein-coupled ATP receptor. FEBS Lett 324:219,1993
27. Filtz TM, Li Q, Boyer JL, Nicholas RA, Harden TK: Expression of a cloned P2Y-purinergic receptor that couples to phospholipase C. Mol Pharmacol 46:8,1994
28. Tokuyama Y, Hara M, Jones EMC, Fan Z, Bell GI: Cloning of rat and mouse P2Y purinoceptors. Biochem Biophys Res Commun 211:211,1995
29. 1 purinoceptor. Br J Pharmacol 118:167,1996
30. 1 receptor. Biochem Biophys Res Comm 221:588,1996
31. 2+ mobilization in brain capillary endothelial cells. J Biol Chem 268:8787,1993
32. Vigne P, Feolde E, Breittmayer JP, Frelin C: Characterization of the effects of 2-methylthio-ATP and 2-chloro-ATP on brain capillary endothelial cells: Similarities to ADP and differences from ATP. Br J Pharmacol 112:775,1994
33. Feolde E, Vigne P, Breittmayer J-P, Frelin C: ATP, a partial agonist of atypical P2Y purinoceptors in rat brain micro vascular endothelial cells. Br J Pharmacol 115:1199,1996
34. Webb TE, Feolde E, Vigne P, Neary JT, Runberg A, Frelin C, Barnard EA: The P2Y purinoceptor in rat brain microvascular endothelial cells couple to inhibition of adenylate cyclase. Br J Pharmacol 119:1385,1996
35. 1 receptor. Mol Pharmacol 50:1323,1996
36. Cazenave JP, Hemmendinger S, Beretz A, Sutter-Bay A, Launay J: L'agrégation plaquettaire: Outil d'investigation clinique et d'étude pharmacologique. Méthodologie. Ann Biol Clin (Paris) 41:167,1983
37. Khym JX: An analytical system for rapid separation of tissue nucleotides at low pressures on conventional anion exchangers. Clin Chem 21:1245,1975
38. 1 receptor: Similarities with the platelet ADP receptor. Mol Pharmacol 53:727,1998
39. Offermans S, Toombs CF, Hu YH, Simon MI: Defective platelet activation in Gαq-deficient mice. Nature 389:183,1997
40. Haslam RJ, Davidson MML, Desjardins JV: Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP. Biochem J 176:83,1978
41. Lanza F, Beretz A, Stierlé A, Hanau D, Kubina M, Cazenave JP: Epinephrine potentiates human platelet activation but is not an aggregating agent. Am J Physiol 255:1276,1988
42. 1 receptor to phospholipase C. Br J Pharmacol 122:1021,1997
43. 2T purinoceptor antagonists: Definition of the role of ADP in arterial thrombosis. Trends Pharmacol Sci 16:179,1995
44. Daniel JL, Dangelmaier C, Jin J, Ashby B, Smith JB, Kunapuli SP: Molecular basis for ADP-induced platelet activation. I. Evidence for three distinct ADP receptors on human platelets. J Biol Chem 273:2024,1998
45. 2 proteins. Biochem J 312:775,1995
46. Hourani SMO, Welford LA, Cusack NJ: Effects of 2-methylthio-adenosine 5′-β, γ-methylenetriphosphonate and 2-ethylthioadenosine 5′-monophosphate on human platelet activation induced by adenosine 5′-diphosphate. Drug Dev Res 38:12,1996
47. Boyer JL, Lazarowski ER, Chen XH, Harden TK: Identification of P2Y-receptor that inhibits adenylyl cyclase. J Pharm Exp Ther 267:1140,1993